Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer
- Resource Type
- Article
- Source
- In
Journal of Cancer Policy September 2022 33 - Subject
- Language
- ISSN
- 2213-5383